Vir Biotechnology, Inc.VIRNASDAQ
Loading
EBITDA Margin Over TimeStrong
Percentile Rank63
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Percentile
P63
Within normal range
vs 3Y Ago
-12.7x
Contraction
Streak
2 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM-658.54%+4.0%
2024-685.82%+7.9%
2023-744.53%-1532.4%
202251.98%+33.5%
202138.94%+109.0%
2020-433.55%+98.2%
2019-24396.91%-82.7%
2018-13356.68%+75.5%
2017-54406.04%-